Literature DB >> 19564157

Dynamic expression of peptidylarginine deiminase 2 in human monocytic leukaemia THP-1 cells during macrophage differentiation.

Ikuko Hojo-Nakashima1, Ryo Sato, Katsuhiko Nakashima, Teruki Hagiwara, Michiyuki Yamada.   

Abstract

Peptidylarginine deiminases (PADs) consist of five enzymes which are widely distributed in human and rodent tissues. The two types of enzymes are found in human peripheral blood cells; PAD4 mainly in granulocytes and monocytes and PAD2 in lymphocytes and macrophages. Little is known about the regulation of PAD expression in macrophages. Here, we report that PAD2 is expressed in human monocytic leukaemia THP-1 cells during differentiation into macrophages by 12-O-tetradecanoylphorbol-13-acetate. During this differentiation, the levels of PAD2 mRNA and protein increased concomitantly, indicating the transcriptional regulation of PAD2 gene expression in the cells. The treatment of THP-1-derived macrophages with calcium ionophore A23187 generated vimentin deimination and resulted in the disruption of vimentin filament organization. We discuss the possible role of vimentin deimination in cell physiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564157     DOI: 10.1093/jb/mvp097

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  9 in total

1.  Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.

Authors:  John W Wizeman; Royce Mohan
Journal:  Biochem Biophys Res Commun       Date:  2017-04-08       Impact factor: 3.575

2.  Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.

Authors:  Ulrike Harre; Dan Georgess; Holger Bang; Aline Bozec; Roland Axmann; Elena Ossipova; Per-Johan Jakobsson; Wolfgang Baum; Falk Nimmerjahn; Eszter Szarka; Gabriella Sarmay; Grit Krumbholz; Elena Neumann; Rene Toes; Hans-Ulrich Scherer; Anca Irinel Catrina; Lars Klareskog; Pierre Jurdic; Georg Schett
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

Review 3.  The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.

Authors:  Katleen Van Steendam; Kelly Tilleman; Dieter Deforce
Journal:  Rheumatology (Oxford)       Date:  2011-01-27       Impact factor: 7.580

4.  Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.

Authors:  Pei-Chen Hsu; Ya-Fan Liao; Chin-Li Lin; Wen-Hao Lin; Guang-Yaw Liu; Hui-Chih Hung
Journal:  Mol Cells       Date:  2014-05-22       Impact factor: 5.034

Review 5.  Deimination, Intermediate Filaments and Associated Proteins.

Authors:  Julie Briot; Michel Simon; Marie-Claire Méchin
Journal:  Int J Mol Sci       Date:  2020-11-19       Impact factor: 5.923

6.  PADI2 Polymorphisms Are Significantly Associated With Rheumatoid Arthritis, Autoantibodies Serologic Status and Joint Damage in Women from Southern Mexico.

Authors:  Iris Paola Guzmán-Guzmán; Claudia Isabel Ramírez-Vélez; Ramcés Falfán-Valencia; José Eduardo Navarro-Zarza; Ilse Adriana Gutiérrez-Pérez; Oscar Zaragoza-García; Mónica Ramírez; Natividad Castro-Alarcón; Isela Parra-Rojas
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

Review 7.  Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and Perspectives.

Authors:  Zhenyu Wu; Patrick Li; Yuzi Tian; Wenlu Ouyang; Jessie Wai-Yan Ho; Hasan B Alam; Yongqing Li
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

8.  The Essential Role of Peptidylarginine Deiminases 2 for Cytokines Secretion, Apoptosis, and Cell Adhesion in Macrophage.

Authors:  Hui-Chun Yu; Chien-Hsueh Tung; Kuang-Yung Huang; Hsien-Bin Huang; Ming-Chi Lu
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

Review 9.  An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders.

Authors:  Mohammed Alghamdi; Doaa Alasmari; Amjad Assiri; Ehab Mattar; Abdullah A Aljaddawi; Sana G Alattas; Elrashdy M Redwan
Journal:  J Immunol Res       Date:  2019-11-25       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.